Plasma rich in growth factors (PRGF® – Endoret®) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts while inhibits and reverts TGF-{beta}1-induced myodifferentiation.
Invest Ophthalmol Vis Sci. 2011; 52(9):6066-73
Authors:
Anitua E, Sanchez M, Merayo Lloves J, De la Fuente M, Muruzabal F, Orive G.
Authors:
Anitua E, Sánchez M, Orive G.
The importance of understanding what is PRGF and what is not.
J Shoulder and Elbow Surgery 2011, 20, e23-e24
Authors:
Anitua E, Sánchez M, Prado R, Orive G.
The P makes the difference in plasma rich in growth factors (PRGF) technology.
Platelets (In press 2011)
Authors:
Anitua E, Alkhraisat MH, Orive G.
Perspectives and challenges in regenerative medicine using Plasma Rich in Growth Factors.
Journal of Controlled Release (In Press 2011)
Authors:
Anitua E, Sánchez M, Orive G.
Potential of endogenous regenerative technology for in situ regenerative medicine.
Adv Drug Deliv Rev. 2010; 62 (7-8):741-52
Authors:
Sanchéz M, Anitua E, Andia I.
Poor standardization in platelet-rich therapies hampers advancement.
Arthroscopy, 2010, 26 (6), 725-6
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
Delivering growth factors for therapeutics.
Trends Pharmacol Sci 2008;29:37-41
Authors:
Alio J.L., Pastor S, Ruiz Colecha J, Rodriguez A, Artola A.
Treatment of ocular surface syndrome after LASIK with autologous platelet rich plasma.
J Refract Surg 2007; 23: 617-619
Authors:
Germán A Rocha, Arantxa Acera, Juan A Durán
Laser in situ Keratomileusis Flap Necrosis After Trigeminal Nerve Palsy.
Arch Ophtalmol, 2007; 125 (10):1423-1425
Authors:
Alio J, Abad M, Artola A, L. Rodriguez-Prats J, Pastor S, Ruiz-Colecha J
Use of Autologous Platelet-Rich Plasma in the Treatment of Dormant Corneal Ulcers.
Ophtalmology, 2007; 114 (7): 1286-1293
Authors:
Alio J, Colecha J, Pastor S, Rodriguez A, Artola A.
Symptomatic Dry Eye Treatment with Autologous Platelet-Rich Plasma
Ophtalmic Res 2007; 39: 124-129
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.
Biomaterials 2007; 28: 4551-4560.
Authors:
Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I.
New insights into and novel applications for platelet-rich fibrin therapies.
Trends Biotechnology 2006;5:227-234.
Authors:
Márkez R, Montero I.
Subconjuntival application of regenerative factor rich plasma for the treatment of ocular alkali burns.
[ See Abstract ]Eur J Ophthalmol 2009; 19: 909-915